 RADNOR, Pa., July 19, 2021 PRNewswire -- NRx Pharmaceuticals Nasdaq: NRXP, will present data at the Disease Control and Prevention Summit on July 21, 2021 at 10:10 EST, via the following link: NRx Pharmaceuticals Presents Evidence ZYESAMITM aviptadil Helps Prevent Cytokine Storm in Patients with COVID-19 The presentation identifies a statistically significant effect of ZYESAMITM aviptadil in preventing the sharp rise in cytokines, commonly associated with mortality in patients with COVID-19. 